Rheumatologists News and Research

RSS
CME program for understanding latest treatment and research on Dupuytren's disease

CME program for understanding latest treatment and research on Dupuytren's disease

Physicians increase prescription of new biologics

Physicians increase prescription of new biologics

Xanodyne Pharmaceuticals, Ferring Pharmaceuticals sign co-promotion agreement for Zipsor

Xanodyne Pharmaceuticals, Ferring Pharmaceuticals sign co-promotion agreement for Zipsor

Arthritis Foundation supports Congress’ efforts for meaningful health care reform

Arthritis Foundation supports Congress’ efforts for meaningful health care reform

BioTrends publishes new LaunchTrends report on Actemra

BioTrends publishes new LaunchTrends report on Actemra

Study finds sizeable position for Actemra in rheumatoid arthritis treatment paradigm

Study finds sizeable position for Actemra in rheumatoid arthritis treatment paradigm

Actemra: 38% of rheumatologists have commenced treatment

Actemra: 38% of rheumatologists have commenced treatment

Report provides comprehensive insight into how physicians classify and treat patients with gout

Report provides comprehensive insight into how physicians classify and treat patients with gout

Researchers receive grant to study how ILD appears in patients with autoimmune diseases

Researchers receive grant to study how ILD appears in patients with autoimmune diseases

ACR REF Clinician Scholar Education Award for rheumatology health professionals

ACR REF Clinician Scholar Education Award for rheumatology health professionals

HSS supports Arthritis Foundation's educational campaign for osteoarthritis

HSS supports Arthritis Foundation's educational campaign for osteoarthritis

New biomarker may predict treatment outcomes in RA patients

New biomarker may predict treatment outcomes in RA patients

Abaxis' new CRP assay receives FDA marketing clearance

Abaxis' new CRP assay receives FDA marketing clearance

Market for chronic tophaceous gout medications will be led by drug that resolves tophi in less than a year

Market for chronic tophaceous gout medications will be led by drug that resolves tophi in less than a year

New report on launch trend of Roche's Actemra

New report on launch trend of Roche's Actemra

UCB's Cimzia gains market share of Centocor's Simponi

UCB's Cimzia gains market share of Centocor's Simponi

Study evaluates anemia treatment approaches adopted by different specialists

Study evaluates anemia treatment approaches adopted by different specialists

Achievements in lupus research, education and advocacy cause for celebration and hope

Achievements in lupus research, education and advocacy cause for celebration and hope

Cold weather can trigger Raynaud's disease

Cold weather can trigger Raynaud's disease

SonoSite offers SonoAccess iPhone application for musculoskeletal physicians

SonoSite offers SonoAccess iPhone application for musculoskeletal physicians

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.